Sessile Serrated Lesions, SSLs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) SSLs 2) Age > 35 and 10mm and <19mm 4) Absence of risk of dysplasia 5)Agree to participate in this clinical trial and sign informed consent
Exclusion criteria
Exclusion criteria: 1) Presence of risk of dysplasia 2) Biopsy was performed preoperatively 3)Postoperative pathology did not support the diagnosis of SSLs 4)Recurrent SSLs after endoscopic resection 5)Patients in poor condition, who could not tolerate or cooperate with the examination 6)Patients with a history of inflammatory bowel disease 7)Anticoagulation or antiplatelet medication that could not be suspended 8)unwillingness to participate in the trial or provide a signed informed consent.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| recurrence rate ;immediate postpolypectomy bleeding,IPB;the rate delayed postpolypectomy bleeding; | — |
Primary
| Measure | Time frame |
|---|---|
| the incomplete resecttion rate; | — |
Countries
China
Contacts
Shanghai Tenth People's Hospital